GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

CardioComm Solutions EKG.V · CAD

Health Care · TSX Venture · 🇨🇦 Canada

Compare

0.01

0.00%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CAD, from our data supplier.

FY2025

Revenue

C$272,158

FY2016FY2025

Net income

−C$529,488

FY2016FY2025

Free cash flow

−C$455,587

FY2016FY2025

Shareholders' equity

−C$689,416

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueC$272,158C$526,676C$876,414C$995,814C$682,511C$834,785C$874,888C$1.1mC$1.7mC$1.6m
Research and development————C$11,144C$5,813C$24,562C$94,875C$87,650C$81,603
Operating income−C$557,128−C$261,164−C$206,031−C$73,754−C$211,860−C$61,233−C$411,203−C$503,314C$161,662−C$8,127
Net income−C$529,488−C$194,576−C$97,326−C$2,455C$283−C$63,606−C$1.1m−C$577,063C$39,609−C$23,057
Diluted earnings per share-0.00-0.00-0.00-0.000.00-0.00-0.01-0.000.00-0.00

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsC$155,041C$218,632C$341,997C$279,724C$486,472C$360,617C$323,384C$1.1mC$1.5mC$1.1m
Total liabilitiesC$844,457C$495,210C$846,647C$687,048C$909,847C$1.0mC$1.2mC$1.2mC$1.1mC$1.2m
DebtC$132,372————C$290,000—C$600,000C$600,000C$600,000
Shareholders' equity−C$689,416−C$276,578−C$504,650−C$407,324−C$423,375−C$670,318−C$895,809−C$68,413C$489,316−C$7,741
Shares outstanding151m151m151m151m150m141m140m140m111m151m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−C$453,082−C$110,660−C$54,067C$54,516−C$120,797C$39,401−C$61,886−C$192,532−C$291,704−C$204,158
Capital spending−C$2,505−C$5,004−C$2,024−C$2,200−C$2,200−C$13,368−C$5,865−C$2,499−C$1,240−C$477
Free cash flow−C$455,587−C$115,664−C$56,091C$52,316−C$122,997C$26,033−C$67,751−C$195,031−C$292,944−C$204,635

Latest quarters

By quarter end

Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024
RevenueC$56,011C$44,074C$72,032C$100,041C$170,391C$140,020C$99,202C$117,063
Operating income−C$149,942−C$173,266−C$148,157−C$85,763−C$18,261−C$31,503−C$98,886−C$84,103
Net income−C$196,704−C$169,778−C$124,262−C$18,113−C$92,674−C$77,516−C$69,874C$45,488
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.00-0.000.00
Total assetsC$155,041C$256,236C$222,076C$249,133C$218,632C$332,530C$357,992C$327,266
DebtC$132,372———————
Shareholders' equity−C$689,416−C$567,737−C$418,953−C$294,691−C$276,578−C$183,871−C$526,681−C$456,807

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-35.1%-20.1%-16.9%
Operating income96.2%55.5%-1.1%
Net income499.7%52.8%-1.2%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-102.4%-41.1%-32.7%-24.7%
Net margin-90.6%-30.8%-21.2%-27.9%

Valuation history

At each fiscal year end

FY2025
Price to earnings-0.2
Price to sales0.3

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 5-to-1 reverse split · 26 Nov 2007
  • 3-to-1 reverse split · 7 Dec 1998

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.